Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • CareersExpand
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / FDA - Page 26

FDA

FDA approved first biosimilar for the treatment of certain breast and stomach cancers
Biotechnology | Disease | FDA | Oncology | Therapeutics

FDA approved first biosimilar for the treatment of certain breast and stomach cancers

On Dec. 1, 2017, the U.S. Food and Drug Administration (FDA) approved Mylan’s Ogivri (trastuzumab-dkst) as a biosimilar…

Read More FDA approved first biosimilar for the treatment of certain breast and stomach cancersContinue

Genentech drug Hemlibra (emicizumab-kxwh) was approved
Disease | FDA | Therapeutics

Genentech drug Hemlibra (emicizumab-kxwh) was approved

On Nov. 16, 2017, the the U.S. Food and Drug Administration (FDA) approved the Genentech drug Hemlibra (emicizumab-kxwh)…

Read More Genentech drug Hemlibra (emicizumab-kxwh) was approvedContinue

FDA licensed Heplisav-B, the new hepatitis B vaccine from Dynavax, for use in adults age 18 and older
FDA | Life Science History

FDA licensed Heplisav-B, the new hepatitis B vaccine from Dynavax, for use in adults age 18 and older

On Nov. 9, 2017, Dynavax Technologies announced that the U.S. Food and Drug Administration (FDA) had approved HEPLISAV-B…

Read More FDA licensed Heplisav-B, the new hepatitis B vaccine from Dynavax, for use in adults age 18 and olderContinue

FDA licensed Shingrix, the new shingles vaccine from GlaxoSmithKline, for use in adults age 50 and older
FDA | Life Science History

FDA licensed Shingrix, the new shingles vaccine from GlaxoSmithKline, for use in adults age 50 and older

On Oct. 23, 2017, GlaxoSmithKline announced the U.S. Food and Drug Administration (FDA) had approved Shingrix (Zoster Vaccine…

Read More FDA licensed Shingrix, the new shingles vaccine from GlaxoSmithKline, for use in adults age 50 and olderContinue

FDA approval brought first gene therapy to the U.S.
FDA | Life Science History | Therapeutics

FDA approval brought first gene therapy to the U.S.

On Aug. 30, 2017, the U.S. Food and Drug Administration (FDA) approved Kymriah (tisagenlecleucel) for certain pediatric and…

Read More FDA approval brought first gene therapy to the U.S.Continue

Adamas announced FDA approval of GOCOVRI as first and only medication fortreatment of Dyskinesia in Parkinson’s disease Patients
Biotechnology | Disease | FDA | Neurology | Therapeutics

Adamas announced FDA approval of GOCOVRI as first and only medication fortreatment of Dyskinesia in Parkinson’s disease Patients

On Aug. 24, 2017, Adamas announced U.S. Food and Drug Administration (FDA) approval of GOCOVRI as First and…

Read More Adamas announced FDA approval of GOCOVRI as first and only medication fortreatment of Dyskinesia in Parkinson’s disease PatientsContinue

Seqirus announced major advances in pandemic preparedness
Biotechnology | FDA | Infectious Disease | Influenza | Vaccine

Seqirus announced major advances in pandemic preparedness

On Aug. 7, 2017, Seqirus announced that the accelerated development of cell-based manufacturing technology at its state-of-the-art manufacturing…

Read More Seqirus announced major advances in pandemic preparednessContinue

The FDA unveiled a strategic plan to completely eliminate the agency’s existing orphan designation backlog
Biotechnology | FDA | Therapeutics | Vaccine

The FDA unveiled a strategic plan to completely eliminate the agency’s existing orphan designation backlog

On Jun. 29, 2017, the U.S. Food and Drug Administration (FDA) unveiled a strategic plan to completely eliminate…

Read More The FDA unveiled a strategic plan to completely eliminate the agency’s existing orphan designation backlogContinue

The FDA approved Endari developed by Dr Yutaka Niihara at LA Biomed
FDA | Life Science History

The FDA approved Endari developed by Dr Yutaka Niihara at LA Biomed

On Jun. 7, 2017 the FDA approved Endari (L-glutamine oral powder) for patients age five years and older…

Read More The FDA approved Endari developed by Dr Yutaka Niihara at LA BiomedContinue

Genentech drug Ocrevus (ocrelizumab) was approved
Biotechnology | FDA | Therapeutics

Genentech drug Ocrevus (ocrelizumab) was approved

On Mar. 28, 2017, Genentech drug Ocrevus (ocrelizumab) was approved by the U.S. Food and Drug Administration (FDA)…

Read More Genentech drug Ocrevus (ocrelizumab) was approvedContinue

First drug approved by the FDA for treatment of canine lymphoma
Biotechnology | FDA | Therapeutics

First drug approved by the FDA for treatment of canine lymphoma

On Jan. 3, 2017, the U.S. Food and Drug Administration’s Center for Veterinary Medicine (CVM) announced the conditional…

Read More First drug approved by the FDA for treatment of canine lymphomaContinue

FDA approved extending the age range for use of FluLaval Quadrivalent to include children 6 to 35 months of age
Biotechnology | FDA | Infectious Disease | Influenza | Vaccine

FDA approved extending the age range for use of FluLaval Quadrivalent to include children 6 to 35 months of age

On Nov. 18, 2016, the U.S. Food and Drug Administration (FDA) approved extending the age range for use…

Read More FDA approved extending the age range for use of FluLaval Quadrivalent to include children 6 to 35 months of ageContinue

Roswell Park study brought Cuban lung cancer vaccine to U.S. Patients
Biotechnology | FDA | Non-Profit Research | Oncology | Vaccine

Roswell Park study brought Cuban lung cancer vaccine to U.S. Patients

On Oct. 27, 2016, Roswell Park Cancer Institute announced it had received authorization from the U.S. Food and…

Read More Roswell Park study brought Cuban lung cancer vaccine to U.S. PatientsContinue

Genentech drug Tecentriq (atezolizumab) was approved
Biotechnology | Chemical | Disease | FDA | Oncology | Therapeutics

Genentech drug Tecentriq (atezolizumab) was approved

On Oct. 18, 2016, the U.S. Food and Drug Administration (FDA) approved TECENTRIQ® (atezolizumab) for the treatment of…

Read More Genentech drug Tecentriq (atezolizumab) was approvedContinue

Seqirus received FDA approval for AFLURIA® QUADRIVALENT (Influenza Vaccine) for people 18 years of age and older
Biotechnology | FDA | Infectious Disease | Influenza | Therapeutics | Vaccine

Seqirus received FDA approval for AFLURIA® QUADRIVALENT (Influenza Vaccine) for people 18 years of age and older

On Aug. 29, 2016, Seqirus announced that the U.S. Food and Drug Administration (FDA) had approved AFLURIA® QUADRIVALENT…

Read More Seqirus received FDA approval for AFLURIA® QUADRIVALENT (Influenza Vaccine) for people 18 years of age and olderContinue

InBios received FDA EUA for its ZIKV Detect IgM Capture ELISA diagnostic test for antibodies in human serum
Biotechnology | Diagnostics | FDA

InBios received FDA EUA for its ZIKV Detect IgM Capture ELISA diagnostic test for antibodies in human serum

On Aug. 19, 2016, InBios announced that it had received an Emergency Use Authorization (EUA) from the U.S….

Read More InBios received FDA EUA for its ZIKV Detect IgM Capture ELISA diagnostic test for antibodies in human serumContinue

FDA extended the age indication for PCV13 (Prevnar 13) to include adults age 18 through 49 years
FDA | Life Science History

FDA extended the age indication for PCV13 (Prevnar 13) to include adults age 18 through 49 years

On Jul. 12, 2016, Pfizer announced that Prevnar 13ᆴ (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) received FDA…

Read More FDA extended the age indication for PCV13 (Prevnar 13) to include adults age 18 through 49 yearsContinue

FDA approved revisions in package insert for YF-Vax reflected changes to International Health Regulations and recommendations
FDA | Life Science History

FDA approved revisions in package insert for YF-Vax reflected changes to International Health Regulations and recommendations

On Jun. 15, 2016, the FDA approved revisions in the package insert for YF-Vax to reflect changes to…

Read More FDA approved revisions in package insert for YF-Vax reflected changes to International Health Regulations and recommendationsContinue

FDA approved Vaxchora for the prevention of cholera
Biotechnology | FDA | Vaccine

FDA approved Vaxchora for the prevention of cholera

On Jun. 10, 2016, the U.S. Food and Drug Administration (FDA) approved Vaxchora, a vaccine for the prevention…

Read More FDA approved Vaxchora for the prevention of choleraContinue

FDA revised the Nutrition and Supplement Facts Labels
FDA | Life Science History

FDA revised the Nutrition and Supplement Facts Labels

On May 27, 2016, the Food and Drug Administration (FDA) announced it had amended its labeling regulations for…

Read More FDA revised the Nutrition and Supplement Facts LabelsContinue

FDA approved Hiberix for full Hib vaccineᅠ series
Biotechnology | FDA | Infectious Disease | Vaccine

FDA approved Hiberix for full Hib vaccineᅠ series

On Apr. 29, 2016, GlaxoSmithKline Biologicals in Research Triangle Park, North Carolina, received U.S. Food and Drug Administration…

Read More FDA approved Hiberix for full Hib vaccineᅠ seriesContinue

FDA approved changes to vaccine administrationᅠschedule for Trumenba vaccine
FDA | Life Science History

FDA approved changes to vaccine administrationᅠschedule for Trumenba vaccine

On Jun. 14, 2016, the FDA approved changes to vaccine administrationᅠschedule for Trumenba vaccine produced by Wyeth Pharmaceuticals,…

Read More FDA approved changes to vaccine administrationᅠschedule for Trumenba vaccineContinue

Genentech drug Venclexta (venetoclax) was approved
Biotechnology | FDA | Oncology | Therapeutics

Genentech drug Venclexta (venetoclax) was approved

On Apr. 11, 2016,  the U.S. Food and Drug Administration (FDA) announced that it had granted accelerated approval…

Read More Genentech drug Venclexta (venetoclax) was approvedContinue

FDA expanded Gardasil 9 licensure to include males age 16ヨ26 years
FDA | Life Science History

FDA expanded Gardasil 9 licensure to include males age 16ヨ26 years

On Dec. 14, 2015, the FDA expanded Merck’s Gardasil 9 licensure to include males age 16ヨ26 years. The…

Read More FDA expanded Gardasil 9 licensure to include males age 16ヨ26 yearsContinue

Genentech drug Alecensa (alectinib) was approved by FDA
Biotechnology | Diagnostics | FDA | Therapeutics

Genentech drug Alecensa (alectinib) was approved by FDA

On Dec. 11, 2015, Genentech announced that it’s drug Alecensa (alectinib) was approved by the U.S. Food and…

Read More Genentech drug Alecensa (alectinib) was approved by FDAContinue

FDA approved new injectable influenza vaccine, Fluad, for use in people age 65 years and older
Biotechnology | FDA | Infectious Disease | Influenza | Vaccine

FDA approved new injectable influenza vaccine, Fluad, for use in people age 65 years and older

On Nov. 25, 2015, Seqirus announced that the U.S. Food and Drug Administration (FDA) had approved Fluad™ (Influenza…

Read More FDA approved new injectable influenza vaccine, Fluad, for use in people age 65 years and olderContinue

The FDA approved AquaBounty Technologies’ application to sell the AquAdvantage genetically engineered salmon
Biotechnology | FDA | Marine Science

The FDA approved AquaBounty Technologies’ application to sell the AquAdvantage genetically engineered salmon

On Nov. 19, 2015, AquaBounty Technologies announced the U.S. Food and Drug Administration (FDA) had approved the Company’s…

Read More The FDA approved AquaBounty Technologies’ application to sell the AquAdvantage genetically engineered salmonContinue

Genentech drug Cotellic (cobimetinib) was approved
Biotechnology | FDA | Therapeutics

Genentech drug Cotellic (cobimetinib) was approved

On Nov. 10, 2015, Genentech announed that its drug Cotellic (cobimetinib) was approved by the U.S. Food and…

Read More Genentech drug Cotellic (cobimetinib) was approvedContinue

CDC published updated ACIP recommendations regarding the intervals between PCV13 and PPSV23 vaccines
Biotechnology | CDC | FDA | NIH | Non-Profit Research | Pharmaceutical | Vaccine

CDC published updated ACIP recommendations regarding the intervals between PCV13 and PPSV23 vaccines

On Sept. 4, 2015, the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices…

Read More CDC published updated ACIP recommendations regarding the intervals between PCV13 and PPSV23 vaccinesContinue

FDA approved injectable drug to eliminate double chin
Biotechnology | FDA | Therapeutics

FDA approved injectable drug to eliminate double chin

On Apr. 29, 2015, the U.S. Food and Drug Administration (FDA) announced it had approved Kybella, an injection…

Read More FDA approved injectable drug to eliminate double chinContinue

Page navigation

Previous PagePrevious 1 … 24 25 26 27 28 … 39 Next PageNext
  • Categories
  • Timeline
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemical
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Life Science Banner Advertising
  • Advertise Your Life Science Jobs

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • Careers
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search